These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 29031992)

  • 1. Assessing the utility of a prognostication model to predict 1-year mortality in patients undergoing radiation therapy for spinal metastases.
    Shi DD; Chen YH; Lam TC; Leonard D; Balboni TA; Schoenfeld A; Skamene S; Cagney DN; Chi JH; Cho CH; Harris M; Ferrone ML; Hertan LM
    Spine J; 2018 Jun; 18(6):935-940. PubMed ID: 29031992
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reliability of a spinal metastasis prognostic score to model 1-year survival.
    Goodwin CR; Schoenfeld AJ; Abu-Bonsrah NA; Garzon-Muvdi T; Sankey EW; Harris MB; Sciubba DM
    Spine J; 2016 Sep; 16(9):1102-8. PubMed ID: 27080411
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessing the utility of a clinical prediction score regarding 30-day morbidity and mortality following metastatic spinal surgery: the New England Spinal Metastasis Score (NESMS).
    Schoenfeld AJ; Le HV; Marjoua Y; Leonard DA; Belmont PJ; Bono CM; Harris MB
    Spine J; 2016 Apr; 16(4):482-90. PubMed ID: 26409416
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modeling 1-year survival after surgery on the metastatic spine.
    Ghori AK; Leonard DA; Schoenfeld AJ; Saadat E; Scott N; Ferrone ML; Pearson AM; Harris MB
    Spine J; 2015 Nov; 15(11):2345-50. PubMed ID: 26160329
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prospective validation of a clinical prediction score for survival in patients with spinal metastases: the New England Spinal Metastasis Score.
    Schoenfeld AJ; Ferrone ML; Schwab JH; Blucher JA; Barton LB; Tobert DG; Chi JH; Shin JH; Kang JD; Harris MB
    Spine J; 2021 Jan; 21(1):28-36. PubMed ID: 32087387
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predicting tumor-specific survival in patients with spinal metastatic renal cell carcinoma: which scoring system is most accurate?
    Massaad E; Hadzipasic M; Alvarez-Breckenridge C; Kiapour A; Fatima N; Schwab JH; Saylor P; Oh K; Schoenfeld AJ; Shankar GM; Shin JH
    J Neurosurg Spine; 2020 Oct; 33(4):529-539. PubMed ID: 32502990
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prospective comparison of the accuracy of the New England Spinal Metastasis Score (NESMS) to legacy scoring systems in prognosticating outcomes following treatment of spinal metastases.
    Schoenfeld AJ; Ferrone ML; Blucher JA; Agaronnik N; Nguyen L; Tobert DG; Balboni TA; Schwab JH; Shin JH; Sciubba DM; Harris MB
    Spine J; 2022 Jan; 22(1):39-48. PubMed ID: 33741509
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design of the prospective observational study of spinal metastasis treatment (POST).
    Schoenfeld AJ; Blucher JA; Barton LB; Schwab JH; Balboni TA; Chi JH; Shin JH; Kang JD; Harris MB; Ferrone ML
    Spine J; 2020 Apr; 20(4):572-579. PubMed ID: 31712164
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessing the utility of the spinal instability neoplastic score (SINS) to predict fracture after conventional radiation therapy (RT) for spinal metastases.
    Shi DD; Hertan LM; Lam TC; Skamene S; Chi JH; Groff M; Cho CH; Ferrone ML; Harris M; Chen YH; Balboni TA
    Pract Radiat Oncol; 2018; 8(5):e285-e294. PubMed ID: 29703703
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictive value of seven preoperative prognostic scoring systems for spinal metastases.
    Leithner A; Radl R; Gruber G; Hochegger M; Leithner K; Welkerling H; Rehak P; Windhager R
    Eur Spine J; 2008 Nov; 17(11):1488-95. PubMed ID: 18787846
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Survival analysis of 254 patients after manifestation of spinal metastases: evaluation of seven preoperative scoring systems.
    Wibmer C; Leithner A; Hofmann G; Clar H; Kapitan M; Berghold A; Windhager R
    Spine (Phila Pa 1976); 2011 Nov; 36(23):1977-86. PubMed ID: 21304424
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic factors in patients with spinal metastasis: a systematic review and meta-analysis.
    Luksanapruksa P; Buchowski JM; Hotchkiss W; Tongsai S; Wilartratsami S; Chotivichit A
    Spine J; 2017 May; 17(5):689-708. PubMed ID: 27988342
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Retrospective evaluation of prognostic factors in metastatic spine disease: serum albumin and primary tumour type are key.
    Cook WH; Baker JF
    ANZ J Surg; 2020 Jun; 90(6):1070-1074. PubMed ID: 32175660
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictors of 30- and 90-Day Survival Following Surgical Intervention for Spinal Metastases: A Prognostic Study Conducted at Four Academic Centers.
    Schoenfeld AJ; Leonard DA; Saadat E; Bono CM; Harris MB; Ferrone ML
    Spine (Phila Pa 1976); 2016 Apr; 41(8):E503-9. PubMed ID: 27064339
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predicting survival for metastatic spine disease: a comparison of nine scoring systems.
    Ahmed AK; Goodwin CR; Heravi A; Kim R; Abu-Bonsrah N; Sankey E; Kerekes D; De la Garza Ramos R; Schwab J; Sciubba DM
    Spine J; 2018 Oct; 18(10):1804-1814. PubMed ID: 29567516
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adverse Outcomes After Palliative Radiation Therapy for Uncomplicated Spine Metastases: Role of Spinal Instability and Single-Fraction Radiation Therapy.
    Lam TC; Uno H; Krishnan M; Lutz S; Groff M; Cheney M; Balboni T
    Int J Radiat Oncol Biol Phys; 2015 Oct; 93(2):373-81. PubMed ID: 26279324
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tokuhashi score is predictive of survival in a cohort of patients undergoing surgery for renal cell carcinoma spinal metastases.
    Petteys RJ; Spitz SM; Rhee J; Goodwin CR; Zadnik PL; Sarabia-Estrada R; Groves ML; Bydon A; Witham TF; Wolinsky JP; Gokaslan ZL; Sciubba DM
    Eur Spine J; 2015 Oct; 24(10):2142-9. PubMed ID: 25772089
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Surgical results of metastatic spinal cord compression (MSCC) from non-small cell lung cancer (NSCLC): analysis of functional outcome, survival time, and complication.
    Park SJ; Lee CS; Chung SS
    Spine J; 2016 Mar; 16(3):322-8. PubMed ID: 26586194
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stereotactic Body Radiotherapy (SBRT) for Spinal Metastases: Who Will Benefit the Most from SBRT?
    Park HJ; Kim HJ; Won JH; Lee SC; Chang AR
    Technol Cancer Res Treat; 2015 Apr; 14(2):159-67. PubMed ID: 24502552
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Comparison of Prognostic Models to Facilitate Surgical Decision-Making for Patients With Spinal Metastatic Disease.
    Wick JB; Kalistratova VS; Jr DP; Fine JR; Boozé ZL; Holland J; Vander Voort W; Hisatomi LA; Villegas A; Conry K; Ortega B; Javidan Y; Roberto RF; Klineberg EO; Le HV
    Spine (Phila Pa 1976); 2023 Apr; 48(8):567-576. PubMed ID: 36799724
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.